Penumbra, Inc. (PEN)
338.72
+0.46
(+0.14%)
USD |
NYSE |
Feb 12, 16:00
338.82
+0.10
(+0.03%)
Pre-Market: 20:00
Penumbra Cash from Investing (Quarterly) : -162.86M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -- |
| Zimmer Biomet Holdings, Inc. | -322.00M |
| Globus Medical, Inc. | -75.84M |
| iRhythm Holdings, Inc. | -89.20M |
| Rapt Therapeutics, Inc. | 8.466M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 58.26M |
| Cash from Financing (Quarterly) | 3.95M |
| Free Cash Flow | 152.62M |
| Free Cash Flow Per Share (Quarterly) | 1.069 |
| Free Cash Flow to Equity (Quarterly) | 45.50M |
| Free Cash Flow to Firm (Quarterly) | 42.31M |
| Free Cash Flow Yield | 1.15% |